JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7060 NF 157

Summary: P2Y11/P2X1 antagonist

<71.85 mg/mL
B7148 TC 1

Summary: σ1 receptor ligand

<14.87 mg/mL
B7354 SU 16f

Target: PDGFR

Summary: PDGFRβ inhibitor

Soluble in DMSO
B7376 Biocytin

Summary: Versatile marker used in anterograde, retrograde and intracellular neuroanatomical investigations and in biotinidase assays.

insoluble in EtOH; insoluble in DMSO; ≥15.77 mg/mL
B7574 AC 261066

Summary: Potent RARβ2 agonist

<35.34 mg/mL
B7603 VU 0364739 hydrochloride

Summary: phospholipase D2 (PLD2) inhibitor

<48.3 mg/mL
A4145 TG101209

Summary: JAK2/3 inhibitor

≥25.5 mg/mL
A4103 LAQ824 (NVP-LAQ824,Dacinostat)
1 Citation

Summary: HDAC inhibitor,potent and novel

insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A1910 Bromodomain Inhibitor, (+)-JQ1
69 Citation

Target: Bromodomains

Summary: BET bromodomain inhibitor

≥22.85 mg/mL